share_log

bluebird bio: bluebird bio, Inc. - Reverse Split Option Symbol: BLUE New Symbol: BLUE1

bluebird bio: bluebird bio, Inc. - Reverse Split Option Symbol: BLUE New Symbol: BLUE1

bluebird bio:bluebird bio公司 - 反向拆分選項 標的: BLUE 新標的: BLUE1
OCC期權清算公司 ·  12/12 02:32

Moomoo AI 已提取核心訊息

bluebird bio, Inc. has announced a 1-for-20 reverse stock split, effective December 13, 2024. The company's stock symbol will change from BLUE to BLUE1 on the effective date. This corporate action will impact the company's options contracts.As a result of the reverse split, the new contract multiplier for options will be 100, and the new deliverable per contract will be 5 new bluebird bio common shares. The underlying price for BLUE1 options will be calculated as 0.05 times the price of BLUE. The new CUSIP for bluebird bio shares will be 09609G209.Option investors are advised to independently evaluate this corporate event and its impact on their investments. The Options Clearing Corporation (OCC) will make adjustments to options and futures based on their by-laws, and these decisions may be subject to change as more information becomes available.
bluebird bio, Inc. has announced a 1-for-20 reverse stock split, effective December 13, 2024. The company's stock symbol will change from BLUE to BLUE1 on the effective date. This corporate action will impact the company's options contracts.As a result of the reverse split, the new contract multiplier for options will be 100, and the new deliverable per contract will be 5 new bluebird bio common shares. The underlying price for BLUE1 options will be calculated as 0.05 times the price of BLUE. The new CUSIP for bluebird bio shares will be 09609G209.Option investors are advised to independently evaluate this corporate event and its impact on their investments. The Options Clearing Corporation (OCC) will make adjustments to options and futures based on their by-laws, and these decisions may be subject to change as more information becomes available.
bluebird bio, Inc. 宣佈將於2024年12月13日實施1比20的反向股票分割。公司的股票標的將在生效日由BLUE變更爲BLUE1。這項公司行動將影響公司的期權合約。由於反向分割,期權的新合約乘數將爲100,每份合約的新交付量將爲5股新的bluebird bio普通股。BLUE1期權的基礎價格將按BLUE價格的0.05倍進行計算。bluebird bio股票的新CUSIP將爲09609G209。期權投資者被建議獨立評估此次公司事件及其對投資的影響。期權清算公司(OCC)將根據其章程對期權和期貨進行調整,這些決定可能會隨着更多信息的公佈而有所變化。
bluebird bio, Inc. 宣佈將於2024年12月13日實施1比20的反向股票分割。公司的股票標的將在生效日由BLUE變更爲BLUE1。這項公司行動將影響公司的期權合約。由於反向分割,期權的新合約乘數將爲100,每份合約的新交付量將爲5股新的bluebird bio普通股。BLUE1期權的基礎價格將按BLUE價格的0.05倍進行計算。bluebird bio股票的新CUSIP將爲09609G209。期權投資者被建議獨立評估此次公司事件及其對投資的影響。期權清算公司(OCC)將根據其章程對期權和期貨進行調整,這些決定可能會隨着更多信息的公佈而有所變化。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息